Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Lin, Juntang  [Clear All Filters]
2021
Guan L, Han Y, Yang C, Lu S, Du J, Li H, Lin J. CRISPR-Cas9-Mediated Gene Therapy in Neurological Disorders. Mol Neurobiol. 2021.
Guo R, Zhang D, Zhang C, Yang Y, Liu H, Yang Y, Lin J. Immunotoxin IHP25-BT with low immunogenicity and off-target toxicity inhibits the growth and metastasis of trastuzumab-resistant tumor cells. Int J Pharm. 2021:121081.
2019
Du J, Ji Y, Qiao L, Liu Y, Lin J. Cellular endo-lysosomal dysfunction in the pathogenesis of non-alcoholic fatty liver disease. Liver Int. 2019.
Liu Q, Du J, Fan J, Li W, Guo W, Feng H, Lin J. Generation and Characterization of Induced Pluripotent Stem Cells from Mononuclear Cells in Schizophrenic Patients. Cell J. 2019;21(2):161-168.
Yang C, Li X, Zhang B, Fu S, Li S, Shen J, Guan L, Qiao L, Lin J. The Mechanism of Rap1 Regulates N-cadherin to Control Neuronal Migration. J Mol Neurosci. 2019.
Liu Y, Niu R, Li W, Lin J, Stamm C, Steinhoff G, Ma N. Therapeutic potential of menstrual blood-derived endometrial stem cells in cardiac diseases. Cell Mol Life Sci. 2019.
2018
Zhu X, Liu Y, Yu J, Du J, Guo R, Feng Y, Zhong G, Jiang Y, Lin J. LncRNA HOXA-AS2 represses endothelium inflammation by regulating the activity of NF-κB signaling. Atherosclerosis. 2018;281:38-46.
Zhu X, Du J, Yu J, Guo R, Feng Y, Qiao L, Xu Z, Yang F, Gong G, Liu F, et al. LncRNA NKILA regulates endothelium inflammation by controlling a NF-κB/KLF4 positive feedback loop. J Mol Cell Cardiol. 2018.
2016
Chen H, Nan WB, Wei X, Wang Y, Lv F, Tang H, Li Y, Zhou C, Lin J, Zhu W, et al. Toxicity, pharmacokinetics, and in vivo efficacy of biotinylated chitosan surface-modified PLGA nanoparticles for tumor therapy. Artif Cells Nanomed Biotechnol. 2016:1-8.